
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imaging, Diagnosis, Prognosis |
B Activation Correlates with Better Prognosis and Akt Activation in Human Gastric Cancer
Authors' Affiliations: Department of 1 Anatomy, Seoul National University College of Medicine, Seoul, Korea; 2 Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi, Korea; 3 Department of Microbiology, Hanyang University College of Medicine; 4 Department of Pathology, Seoul National University College of Medicine; and 5 Division of Radiation Effect Research, Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Seoul, Korea
Requests for reprints: Seon Young Nam, Division of Radiation Effect Research, Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Seoul 132-703, Korea. Phone: 82-2-3499-6691; Fax: 82-2-3499-6660; E-mail: seonynam{at}khnp.co.kr.
Purpose: Because the biological significance of constitutive nuclear factor-
B (NF-
B) activation in human gastric cancer is unclear, we undertook this study to clarify the regulatory mechanism of NF-
B activation and its clinical significance.
Experimental Design: Immunohistochemistry for NF-
B/RelA was done on 290 human gastric carcinoma specimens placed on tissue array slides. The correlations between NF-
B activation and clinicopathologic features, prognosis, Akt activation, tumor suppressor gene expression, or Bcl-2 expression were analyzed. We also did luciferase reporter assay, Western blot analysis, and reverse transcription-PCR using the SNU-216 human gastric cancer cell line transduced with retroviral vectors containing constitutively active Akt or the NF-
B repressor mutant of I
B
.
Results: Nuclear expression of RelA was found in 18% of the gastric carcinomas and was higher in early-stage pathologic tumor-node-metastasis (P = 0.019). A negative correlation was observed between NF-
B activation and lymphatic invasion (P = 0.034) and a positive correlation between NF-
B activation and overall survival rate of gastric cancer patients (P = 0.0228). In addition, NF-
B activation was positively correlated with pAkt (P = 0.047), p16 (P = 0.004), adenomatous polyposis coli (P < 0.001), Smad4 (P = 0.002), and kangai 1 (P < 0.001) expression. An in vitro study showed that NF-
B activity in gastric cancer cells is controlled by and controls Akt.
Conclusions: NF-
B activation was frequently observed in early-stage gastric carcinoma and was significantly correlated with better prognosis and Akt activation. These findings suggest that NF-
B activation is a valuable prognostic variable in gastric carcinoma.
Key Words: NF-
B prognosis gastric cancer Akt
This article has been cited by other articles:
![]() |
X. Liu, B. Wang, X. Ma, and Y. Guo NF-{kappa}B Activation Through the Alternative Pathway Correlates with Chemoresistance and Poor Survival in Extranodal NK/T-cell Lymphoma, Nasal Type Jpn. J. Clin. Oncol., July 1, 2009; 39(7): 418 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Liang, H. Wang, A. Rashid, T.-H. Tan, R. F. Hwang, S. R. Hamilton, J. L. Abbruzzese, D. B. Evans, and H. Wang Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma Clin. Cancer Res., November 1, 2008; 14(21): 7043 - 7049. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Feng, R. E. Brown, C. D. Trung, W. Li, L. Wang, T. Khoury, S. Alrawi, J. Yao, K. Xia, and D. Tan Morphoproteomic Profile of mTOR, Ras/Raf Kinase/ERK, and NF-{kappa}B Pathways in Human Gastric Adenocarcinoma Ann. Clin. Lab. Sci., January 1, 2008; 38(3): 195 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sethi, B. Sung, and B. B. Aggarwal Nuclear Factor-{kappa}B Activation: From Bench to Bedside Experimental Biology and Medicine, January 1, 2008; 233(1): 21 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, X. Jin, F. Wang, S. Wang, C. Deng, Z. Gao, and C. Guo Combined Prognostic Value of Both RelA and I{kappa}B-{alpha} Expression in Human Non Small Cell Lung Cancer Ann. Surg. Oncol., December 1, 2007; 14(12): 3581 - 3592. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |